Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
about
Biologic complexity in sickle cell disease: implications for developing targeted therapeuticsBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseUmbilical cord blood: an evolving stem cell source for sickle cell disease transplantsStroke in patients with sickle cell disease.Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.How I manage cerebral vasculopathy in children with sickle cell disease.Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell diseaseTranscranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseNational trends in incidence rates of hospitalization for stroke in children with sickle cell disease.Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.How I treat and manage strokes in sickle cell disease.Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell diseaseTransfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.Central nervous system complications of sickle cell disease in children: an overview.Treatment of arterial ischemic stroke in children.Acute silent cerebral ischemic events in children with sickle cell anemia.Current management of sickle cell anemia.Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Sickle cell disease: management options and challenges in developing countries.Severe sickle cell disease--pathophysiology and therapy.Stem-cell transplantation in children and adults with sickle cell disease: an update.Cerebral infarction in children with sickle cell disease: a concise overview.The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.Indications and complications of transfusions in sickle cell disease.Transition from paediatric to adult care for patients with sickle cell disease.Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.Sickle Cell Disease and Stroke: Diagnosis and Management.Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.Design of the silent cerebral infarct transfusion (SIT) trial.
P2860
Q21284789-B528A963-9751-4257-9F52-E293C3C28EA3Q24202463-1E257AE9-4EF5-4EA3-B5CF-EA45CB835150Q26853559-76B349CB-9A73-4849-B57E-1BD0525F8CA3Q30650303-877D020E-0920-4D44-8CEB-21D4F4D0820BQ30830149-DE989730-3738-4643-9931-BEF42CF5B371Q30945117-8D511F6D-C5A3-440B-AF89-FF58D27B1373Q33165774-18797473-A773-4F09-BCD1-4AD13B27C5E3Q33679897-E59DC70C-2DC3-4C03-B339-F6F400B5823AQ34057698-89128E20-18DD-465E-8EF8-B80A621ABE7BQ34098387-888C81F1-ADF6-43AF-810D-7C3AEAB7BC5DQ34557931-ABEF41DE-93DA-49BF-9FB5-A7E739EC5BEDQ34601055-608C0566-F689-4727-8FE9-85CADE001F0AQ35076607-C48F910C-CB0D-4566-9218-D80AF470CECDQ35209572-C2486D3C-13AB-4578-9894-F625DA20917CQ35743944-E1830241-3627-441A-9620-FEAB1C197376Q35909642-7183B5ED-32CC-48C8-8511-B73EDD64F686Q35953361-FB24425D-6903-4F44-97FD-DCCF9F52BA7EQ36395580-4DE8D735-8505-455A-AD94-47E2DE81E60FQ36490354-A9426C2C-E7F5-44E7-9989-C261E72D1229Q36761420-0BE8AC70-DA26-42A1-A299-B24BD28C3944Q36787348-013B9F41-080B-4D97-958C-3883EF8CF983Q36914931-B44F53D0-D16E-403D-AB67-0B11548A4201Q37040238-BEC092F0-E510-48D1-A5D3-2ACC4F93576DQ37061928-81660FD3-8C4E-43D1-8956-A25DC7EFD4EDQ37154176-A4956A99-61C2-4B8C-BC0D-0035AF4C9BE7Q37401660-653C412E-0E72-4B35-BE1C-44A4728BD95DQ37612447-41AB2E65-24E6-4899-905C-5AE679A6A1BBQ37888719-554B94D1-DECF-4726-BD53-72113D561A5FQ37941865-7CF3B369-C151-4E1F-8771-84BA86965F59Q37955226-E563306B-66D1-4487-BFE5-901F3D459D54Q38008292-CB10B983-B6F1-4F78-9FB2-3F1439E906ADQ38171853-C440F018-ABC1-4364-883C-CFF8624F106DQ38627797-11C58B86-1ECB-401F-ABCD-B0E077CD7A2FQ38732049-BCBFFE53-17D8-4BF2-BB75-59A93B33DECCQ38844495-BD1CDDD3-D2C1-44B4-8565-D8C9FDFBC275Q40290091-E9852B8C-82A9-452A-A9EC-84742F68FDDBQ40526934-431BF804-536E-449F-8F9D-063C250A50ABQ40702431-3E6D7413-C779-453B-B344-1051659222D3Q40829777-420E3337-2E26-44E1-B232-C204138E55DFQ41527748-373CDE86-5006-4904-8B1E-2B57BA9AADA7
P2860
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Risk of recurrent stroke in ch ...... ve years after initial stroke.
@en
type
label
Risk of recurrent stroke in ch ...... ve years after initial stroke.
@en
prefLabel
Risk of recurrent stroke in ch ...... ve years after initial stroke.
@en
P2093
P356
P1476
Risk of recurrent stroke in ch ...... ve years after initial stroke.
@en
P2093
Brian Berman
Charles H Pegelow
Cindy Terrill
Cynthia Price
Daniel Schwartz
Donald Mahoney
Douglas J Scothorn
George R Buchanan
Gerald M Woods
Ingrid Sarniak
P304
P356
10.1067/MPD.2002.122498
P407
P577
2002-03-01T00:00:00Z